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Background
g-cystathionase (CSE) is a rate-limiting enzyme of the
trans-sulfuration pathway which converts methionine and
cystathionine into cysteine and H2S. T cells are deficient
in CSE and cysteine import and therefore are metaboli-
cally dependent on accessory cells for cysteine supply.
Methods and results
In the current study, we demonstrated that pharmacolo-
gical blockade of CSE with the irreversible inhibitor pro-
pargylglycine (PPG) delayed heart allograft rejection
(median survival of 26.5 days instead of 9 in controls)
and abrogated type IV hypersensitivity to keyhole limpet
haemocyanin (Th-1 response), but did not modify anti-
body responses (Th-2 response). The dominant biological
effect of CSE blockade was a repression of the IL-12 p40,
T-Bet and IL-1b transcripts inside the graft paralleled
with a decrease, at the protein level, of IL-12 and IFN-g.
In parallel, we found that tolerance induced by costimu-
lation blockade or immunosuppression after heart and
kidney allotransplantation in the LEW.1W to LEW.1A
rat model was associated with a two to five fold repres-
sion of intragraft CSE, as well as of several other enzymes
of the trans-sulfuration pathway. Monocytes and Dendri-
tic cells treated by PPG or by the reversible CSE inhibi-
tor, b-cyano alanine, as well as by siRNA specific for
CSE, dose-dependently and differentially regulated pro-
duction of IL-12 cytokine. The effect was independent of
NFkB or H2S production, but could be assigned to a
modulation of intracellular cysteine content.
Conclusion
Our results identify CSE as a novel factor that plays a cri-
tical role in IL-12 production by monocytes and DCs by
modulating intracellular cysteine levels, which in turn
controls Th-1 type immune responses.
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